Subscription and demo access

About Interfax
Press Releases
Products & Services
Contact us
Customer Login


09/21 10:22   Putin congratulates Armenia on Independence Day, expresses confidence in further broadening of bilateral partnership
09/21 10:10   Uzbek president set to visit Russia in early 2020
09/21 10:01   Surgutneftegas commissions 40-mln-ton Lenskoye oil field in Yakutia
09/21 09:50   Venezuelan oil minister may visit Moscow in early Oct - source
09/20 22:05   Russia wants Libya to remain unitary state, launch political process - Bogdanov
09/20 22:01   Pskov journalist Prokopyeva indicted for justifying terrorism
09/20 21:57   Zelensky gives 3 months to draft legislation on principles of administrative-territorial division, local elections
09/20 21:43   Kozak optimistic about gas shipments to Moldova via Ukraine in 2020

You can access a demo version of, recieve more information about or subscribe to Interfax publications by filling in and sending the form below.

First name:

Last name:







Please enter the digits in the box below:  |  Interviews  |  Eric Goosby: There is political support in U.S. to partner with Russia on HIV...


October 13, 2011

Eric Goosby: There is political support in U.S. to partner with Russia on HIV prevention and treatment strategies

U.S. Global AIDS Coordinator Eric Goosby, who attended an international conference on ways to prevent AIDS in Moscow on October 10-12, told Interfax in an interview about the role this forum could play in combating HIV, about prospects of developing anti-HIV drugs and about Russian-American partnership in this area.

Question: What role could this forum play in combating HIV?

Answer: I think the world was thrilled when the Russian government decided to convene a discussion on how to address the fight against infectious diseases - HIV, TB and malaria. So we came and we were very interested in supporting the Russian government‘s substantive discussion of these issues.

Q.: What could the United States offer Russia from its practical experience in dealing with this problem and what could the U.S. probably borrow from Russia?

A.: I think the United States has gone its way in understanding how best to respond to this epidemic.

We, too, had to learn that you needed to understand how the virus moves through an individual and how it functions, but also how the virus moves through a population, to position the response as the government, the Department of Health, faces this challenge and to develop the surveillances, so you are aware of where the virus is, geographically and by population.

Once you understand where and how the virus is moving through the population you then position your prevention interventions by targeting individuals and groups that are at highest risks of transmission of that virus.

In every country, including the United States, once that is understood, you have to have political leadership to decide that you are going to engage in responses that target high-risk populations in a respectful, fair but effective manner.

So, the political leadership, matched with the science and the surveillance to know where the virus is, allows the government and the medical institutions to deliver effective antiviral therapies to prevent the movement of the virus through the general population.

In the United States and in every country in which we worked - in Africa, in Southeast Asia, Eastern Europe - every pattern that has been successful required or had political leadership at the top, defining the problem, prioritizing the approach and implementing it through prevention at district levels of systems of care.

The unusual challenge with HIV is that it always highlights the most vulnerable populations - marginal groups, injection drug users, men who have sex with men who are very vulnerable. Women in general are very vulnerable. And this requires that governments and leaderships protect those groups.

The reason that the leadership must assert itself is that populations participating in high-risk behavior have a greater chance of developing HIV and getting infected . But ignoring these high-risk populations inevitably leads to the virus moving to the general population, to people who are not at high risk, who are not using drugs.

So we know how the virus moves through populations. We know how to position our prevention programs. We also have drugs that are very effective in treating people who are HIV positive. Indeed, we are talking about individuals who take anti-HIV drugs and die of something else. People are living 20-30 years after the initiation of the therapy, routinely.

What have we learned from Russia? We have learned its ability to scale-up testing . People know their HIV status. Twenty million people have been tested in Russia over the last year or so. An extraordinary number! Of those, 60 thousand have been identified as HIV positive and all those individuals are being given a treatment. That testing strategy of identifying individuals and their treatment are of interest to the world.

Q.: Are there effective drugs that could slow HIV progressing? Do you think a drug could be developed that would cure HIV patients? Or is it a naive idea? Do you think advanced know-how would help develop an effective medication to combat HIV?

A.: Drugs slow down the virus progression in an individual almost to the point where there is no progression. They are very effective. Individuals who started the anti-viral therapy get to a normal immune function and the majority of them continue to work and care for their families Taking an anti-viral therapy is like being a diabetic or a person with high blood pressure. You take the medicine for the rest of your life, but if you take it you don‘t have the complications of those diseases. HIV is the same. It is very effective although not curative.

The other effect of this therapy is that by taking the therapy you drop the amount of the virus in your blood to when it cannot be found and the ability to infect other people through sex or blood drops almost to zero. So treatment becomes highly effective indeed and becomes a prevention.

So we, for the first time in the history of 30 years of responding to this epidemic, we are in a position to actually put all tools together, we have the tools to stop new infections by treating people aggressively, by treating pregnant women who are HIV positive and using other prevention interventions for high-risk behavior, such as drug therapy for people addicted to drugs and who use needles, which causes the transmission of HIV and hepatitis. These known interventions, these effective interventions now can be deployed effectively in combination with the anti-viral therapy, and stop the spread of HIV.

Q.: Are there plans to organize Russian-American joint research, given the role our countries play in developing advanced medical know-how, and create an effective HIV drug? If such plans exist what their budget could be and is there political support for such initiative?

A.: There is strong political support in the United States to partner with Russian scientists and to better understand prevention strategies, as well as treatment strategies. We have developed a partnership between the National Institute of Health and the Russian Foundation for Basic Research, that is new and will take effect next year. That will allow this type of opportunities to be joined. Co-investigators will move forward with therapies, prevention and treatment.

The other relationship that we have had with Russian scientists for ten or eleven years is the National Institute of Health bringing Russian scientists to all international meetings on HIV. So we have been talking to each other for a very long time on prevention, care, treatment and research efforts.


U.S. Ambassador to Russia John Huntsman, who will leave his post in early October, has given an interview to Interfax in which he speaks about exchanges at the highest level between Moscow and Washington, a possibility of Russias return to G8, as well as his vision of the future of U.S.-Russian relations.

Russian Deputy Foreign Minister Sergei Ryabkov has given an interview to Interfax in which he speaks about the U.S. withdrawal from the Intermediate-range Nuclear Forces Treaty on that is expected on August 2, about Russia‘s response to the U.S. and NATO possible deployment of missiles banned by the treaty, and about whether the Cuban Missile Crisis may repeat itself.

German Foreign Minister Heiko Maas and Russian Foreign Minister Sergei Lavrov will hold negotiations on the sidelines of the Petersburg Dialogue forum in Germany on Thursday. Maas has given an interview to Interfax ahead of the forum, in which he speaks about prospects of settling the conflict in Ukraine, Germanys preparations for ensuring security in the absence of the INF Treaty and attempts to save the Iranian nuclear deal.

German Ambassador to Russia Rudiger von Fritsch, who is leaving Moscow after a five-year mission, told Interfax about the state of affairs in bilateral relations, Germanys position on the Nord Stream 2 project amidst sanction risks, and assessed prospects for settling the crisis in Ukraine under the new authorities in Kyiv.

U.S. Special Representative for Afghanistan Reconciliation Zalmay Khalilzad has given an interview to Interfax in which he speaks about results of the trilateral meeting on Afghanistan settlement that took place in Moscow on April 25, prospects of the intra-Afghan meeting in Doha, and Russia‘s role in the Afghan issue.

NATO Secretary General Jens Stoltenberg has given an interview to Interfax ahead of the Alliances 70th anniversary that is to be celebrated on April 4. He speaks in the interview about the NATOs vision of future relations with Russia, its attitude to the situation surrounding the Intermediate-range Nuclear Forces Treaty (INF) Treaty and the New START Treaty, as well as further plans of expanding the Alliance.

British Ambassador to Russia Laurie Bristow has given an interview to Interfax in which he speaks about the current situation in the relationship between the United Kingdom and Russia, the impact of the Skripal case on it, the restoration of the numbers of diplomatic staff, exchange of information on counter-terrorism, possible introduction of sanctions over the Kerch Strait incident, the INF Treaty, and British-Russian economic relations.


 ©   1991—2019   "Interfax News Agency" JSC. All rights reserved.
Contact information   |   Privacy Policy   |   Interfax offices   |   made by web.finmarket

News and other data on this site are provided for information purposes only, and are not intended for republication or redistribution. Republication or redistribution of Interfax content, including by framing or similar means, is expressly prohibited without the prior written consent of Interfax.

Browse other Interfax sites:   |   IFX.RU   |   Interfax Group   Rambler's Top100